Prof. Dr. Martin C. Müller discusses how oncohematology testing has evolved over the years and explores what exciting advances the future may hold.
Join Dr. Vincent Funari to learn how a comprehensive genomic profiling approach was used for myeloid neoplasms.
Discover how a European laboratory partnered with QIAGEN to implement an end-to-end solution for JAK2 V617F and CALR testing, using a single blood sample.
Discover how precision medicine is helping to overcome the challenges in oncohematology testing to help meet patient and clinical expectations.
Find out why the new European IVDR is such a game-changer and how you can approach the transition to IVDR with confidence.
Get the latest on biomarker research and learn how to address challenges and accelerate your NGS workflow.
